Algorhythm Holdings, Inc.·4

Mar 31, 6:21 AM ET

JUDKOWITZ HARVEY 4

Research Summary

AI-generated summary

Updated

Algorhythm (RIME) Director Harvey Judkowitz Receives Awards

What Happened Harvey Judkowitz, a director of Algorhythm Holdings, Inc. (RIME), was granted two awards on 2025-11-20: a restricted stock award (RSA) for 19,532 shares and a non‑qualified stock option to purchase 19,532 shares. Both transactions are reported with an acquisition price of $0.00 (reported value $0), indicating these were compensation grants under the company's equity plan rather than open‑market purchases or sales.

Key Details

  • Transaction date: 2025-11-20; Form 4 filed: 2026-03-31 (appears to be a late filing vs. the 2-business-day rule).
  • RSA: 19,532 restricted shares granted (reported as acquired at $0.00).
  • Option: Non‑qualified option to purchase 19,532 shares (reported as acquired at $0.00; recorded as a derivative).
  • Vesting: Both the RSA and the option vest in equal quarterly installments over one year from grant (per footnotes).
  • Plan: Grants made under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
  • Shares owned after transaction: not disclosed in the provided excerpt.

Context These awards are standard equity compensation: the RSA is a contingent right to shares that vest over time, and the option gives the right to buy shares as it vests (not an immediate exercise). Because no sale or open‑market purchase occurred, this filing does not indicate an immediate cash investment or liquidation by the insider. The late filing may affect timely disclosure for investors tracking insider activity.